🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was awarded for transformative findings that clarify how the body's defense network targets harmful infections while sparing the body's own cells.

Three esteemed scientists—from Japan Prof. Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—received this honor.

Their work identified specialized "sentinels" within the immune system that eliminate malfunctioning immune cells capable of attacking the organism.

These findings are now enabling innovative treatments for immune disorders and cancer.

The laureates will divide a monetary award valued at 11m SEK.

Decisive Discoveries

"The work has been decisive for comprehending how the immune system functions and why we don't all suffer from serious self-attack conditions," stated the head of the Nobel Committee.

The trio's research explain a core mystery: How does the defense system protect us from numerous invaders while leaving our own tissues unharmed?

The body's protection system employs immune cells that search for indicators of disease, even pathogens and bacteria it has not met before.

Such defenders utilize detectors—known as recognition units—that are generated by chance in a vast number of variations.

This provides the defense network the capacity to fight a wide array of threats, but the randomness of the process inevitably creates white blood cells that may target the body.

Protectors of the Immune System

Scientists earlier understood that some of these problematic white blood cells were eliminated in the thymus—the site where white blood cells mature.

This year's Nobel Prize honors the identification of regulatory T-cells—known as the immune system's "peacekeepers"—which travel through the body to disarm other defenders that attack the body's own tissues.

We know that this process malfunctions in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A prize committee added, "These discoveries have laid the foundation for a novel area of research and spurred the creation of innovative treatments, for example for tumors and autoimmune diseases."

In malignancies, regulatory T-cells block the system from attacking the growth, so research are focused on reducing their quantity.

In self-attack disorders, experiments are exploring boosting T-reg cells so the body is no longer under attack. A comparable approach could also be effective in reducing the risks of organ transplant failure.

Pioneering Experiments

Prof Shimon Sakaguchi, of Osaka University, conducted experiments on rodents that had their thymus extracted, leading to self-attack conditions.

The researcher showed that introducing immune cells from healthy mice could prevent the disease—suggesting there was a mechanism for preventing immune cells from harming the body.

Mary Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were studying an inherited immune disorder in mice and people that resulted in the identification of a gene critical for how regulatory T-cells operate.

"Their groundbreaking research has uncovered how the immune system is kept in check by regulatory T cells, stopping it from mistakenly targeting the healthy cells," commented a prominent biological science expert.

"The research is a striking illustration of how basic physiological study can have far-reaching implications for public health."